BioCatalystWatch
APREWorkspace / APRE / OverviewCompany library
Aprea Therapeutics, Inc. logo

Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. (APRE)

Website

Price
Market cap
Next catalystExpected Q4 2026APR-1051 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

APR-1051

Small molecule

WEE1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

APR-1602

DYRK1A × DYRK1B

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

APR-1051

Small molecule

WEE1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

APR-1602

DYRK1A × DYRK1B

PreINDP1P2P3FilingApproved

Other pipelines

ATRN-W1051

Small molecule

WEE1

PreINDP1P2P3FilingApproved

History / paused

Small molecule

Mutant p53

PreINDP1P2P3FilingApproved

Small molecule

Mutant/inactivated p53

PreINDP1P2P3FilingApproved

Small molecule

Mutant/inactivated p53

PreINDP1P2P3FilingApproved

Small molecule

Mutant/inactivated p53

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

APRE PR & News

PR & News

APRE SEC archive